Corebridge Financial’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,959
Closed -$178K 175
2025
Q1
$178K Sell
18,959
-280
-1% -$2.94K ﹤0.01% 2138
2024
Q4
$176K Sell
19,239
-1,157
-6% -$8.51K ﹤0.01% 2250
2024
Q3
$159K Sell
20,396
-127
-0.6% -$917 ﹤0.01% 2352
2024
Q2
$124K Buy
+20,523
New +$127K ﹤0.01% 2473

Other funds holding ANGO

Corebridge Financial's ANGO Position: Q2 2025 in Review

Corebridge Financial sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 18,959 shares — an estimated $178K sold.

Corebridge Financial first reported a position in ANGO in Q2 2024 and held it in 4 quarters. The position peaked at $178K in Q1 2025. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.

  • Corebridge Financial reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 18,959 AngioDynamics shares in Q2 2025, an estimated $178K.
  • Corebridge Financial first reported a position in AngioDynamics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's AngioDynamics position peaked at $178K in Q1 2025.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.